Petri M - Search Results

1

Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus?

To CH, Petri M. To CH, et al. Among authors: petri m. Arthritis Rheum. 2005 Dec;52(12):4003-10. doi: 10.1002/art.21414. Arthritis Rheum. 2005. PMID: 16320348

2

Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. A controlled, prospective study of forty-four women.

Petri M, Golbus M, Anderson R, Whiting-O'Keefe Q, Corash L, Hellmann D. Petri M, et al. Arthritis Rheum. 1987 Jun;30(6):601-6. doi: 10.1002/art.1780300601. Arthritis Rheum. 1987. PMID: 3111489 Clinical Trial.

3

Urine peptidomic biomarkers for diagnosis of patients with systematic lupus erythematosus.

Pejchinovski M, Siwy J, Mullen W, Mischak H, Petri MA, Burkly LC, Wei R. Pejchinovski M, et al. Among authors: petri ma. Lupus. 2018 Jan;27(1):6-16. doi: 10.1177/0961203317707827. Epub 2017 May 5. Lupus. 2018. PMID: 28474961 Free PMC article.

4

Assessments of fatigue and disease activity in patients with systemic lupus erythematosus enrolled in the Phase 2 clinical trial with blisibimod.

Petri MA, Martin RS, Scheinberg MA, Furie RA. Petri MA, et al. Lupus. 2017 Jan;26(1):27-37. doi: 10.1177/0961203316654767. Epub 2016 Jun 26. Lupus. 2017. PMID: 27353505 Clinical Trial.

5

Genetic associations of LYN with systemic lupus erythematosus.

Lu R, Vidal GS, Kelly JA, Delgado-Vega AM, Howard XK, Macwana SR, Dominguez N, Klein W, Burrell C, Harley IT, Kaufman KM, Bruner GR, Moser KL, Gaffney PM, Gilkeson GS, Wakeland EK, Li QZ, Langefeld CD, Marion MC, Divers J, Alarcón GS, Brown EE, Kimberly RP, Edberg JC, Ramsey-Goldman R, Reveille JD, McGwin G Jr, Vilá LM, Petri MA, Bae SC, Cho SK, Bang SY, Kim I, Choi CB, Martin J, Vyse TJ, Merrill JT, Harley JB, Alarcón-Riquelme ME; BIOLUPUS and GENLES Multicenter Collaborations, Nath SK, James JA, Guthridge JM. Lu R, et al. Among authors: petri ma. Genes Immun. 2009 Jul;10(5):397-403. doi: 10.1038/gene.2009.19. Epub 2009 Apr 16. Genes Immun. 2009. PMID: 19369946 Free PMC article.

6

A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study.

Furie RA, Leon G, Thomas M, Petri MA, Chu AD, Hislop C, Martin RS, Scheinberg MA; PEARL-SC Study. Furie RA, et al. Among authors: petri ma. Ann Rheum Dis. 2015 Sep;74(9):1667-75. doi: 10.1136/annrheumdis-2013-205144. Epub 2014 Apr 19. Ann Rheum Dis. 2015. PMID: 24748629 Clinical Trial.

7

Lupus Atherosclerosis Prevention Study (LAPS).

Petri MA, Kiani AN, Post W, Christopher-Stine L, Magder LS. Petri MA, et al. Ann Rheum Dis. 2011 May;70(5):760-5. doi: 10.1136/ard.2010.136762. Epub 2010 Dec 21. Ann Rheum Dis. 2011. PMID: 21177297 Clinical Trial.

8

Oral candidiasis in systemic lupus erythematosus.

Fangtham M, Magder LS, Petri MA. Fangtham M, et al. Among authors: petri ma. Lupus. 2014 Jun;23(7):684-90. doi: 10.1177/0961203314525247. Epub 2014 Mar 5. Lupus. 2014. PMID: 24598219

9

Hereditary resistance to activated protein C: an uncommon risk factor for thromboembolic disease in lupus patients with antiphospholipid antibodies.

Sasso EH, Suzuki LA, Thompson AR, Petri MA. Sasso EH, et al. Among authors: petri ma. Arthritis Rheum. 1997 Sep;40(9):1720-1. doi: 10.1002/art.1780400925. Arthritis Rheum. 1997. PMID: 9324029 No abstract available.

10

The polymorphic CYP17 allele is not found with increased frequency in systemic lupus erythematosus.

Sullivan KE, Mannery T, Petri MA. Sullivan KE, et al. Among authors: petri ma. Arthritis Rheum. 1998 May;41(5):940-1. doi: 10.1002/1529-0131(199805)41:5<940::AID-ART25>3.0.CO;2-G. Arthritis Rheum. 1998. PMID: 9588749 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results